Literature DB >> 16695339

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). II. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN NORMAL SUBJECTS AND AFTER MINIMAL EXPOSURE TO ARSENICAL SMOKE.

J Wexler1, H Eagle, H J Tatum, H J Magnuson, E B Watson.   

Abstract

Entities:  

Year:  1946        PMID： 16695339      PMCID： PMC435585          DOI： 10.1172/JCI101729

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  3 in total

1.  BAL (BRITISH ANTI-LEWISITE).

Authors:  L L Waters; C Stock
Journal:  Science       Date:  1945-12-14       Impact factor: 47.728

2.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION.

Authors:  M B Sulzberger; R L Baer; A Kanof
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

3.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VIII. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN ARSENICAL INTOXICATION.

Authors:  J A Luetscher; H Eagle; W T Longcope; E B Watson
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808
  3 in total
  4 in total

1.  Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of lewisite burns of the eye with BAL.

Authors:  W F HUGHES
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

2.  Bal in the Treatment of Gold Toxicity.

Authors:  J G Macleod
Journal:  Ann Rheum Dis       Date:  1948       Impact factor: 19.103

3.  The acute distribution of intravenously administered lead acetate in normal and BAL-treated rabbits.

Authors:  M GINSBURG; M WEATHERALL
Journal:  Br J Pharmacol Chemother       Date:  1948-09

4.  Clinical uses of 2,3-dimercaptopropanol (BAL); the treatment of complications of arseno-therapy with BAL (British anti-lewisite).

Authors:  A B CARLETON; R A PETERS
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.